全文获取类型
收费全文 | 10921篇 |
免费 | 764篇 |
国内免费 | 135篇 |
专业分类
耳鼻咽喉 | 92篇 |
儿科学 | 334篇 |
妇产科学 | 838篇 |
基础医学 | 730篇 |
口腔科学 | 226篇 |
临床医学 | 1263篇 |
内科学 | 1913篇 |
皮肤病学 | 131篇 |
神经病学 | 253篇 |
特种医学 | 327篇 |
外国民族医学 | 1篇 |
外科学 | 2057篇 |
综合类 | 1023篇 |
预防医学 | 1615篇 |
眼科学 | 157篇 |
药学 | 630篇 |
中国医学 | 79篇 |
肿瘤学 | 151篇 |
出版年
2024年 | 18篇 |
2023年 | 190篇 |
2022年 | 393篇 |
2021年 | 565篇 |
2020年 | 555篇 |
2019年 | 535篇 |
2018年 | 515篇 |
2017年 | 445篇 |
2016年 | 417篇 |
2015年 | 400篇 |
2014年 | 940篇 |
2013年 | 893篇 |
2012年 | 555篇 |
2011年 | 682篇 |
2010年 | 575篇 |
2009年 | 482篇 |
2008年 | 462篇 |
2007年 | 442篇 |
2006年 | 400篇 |
2005年 | 338篇 |
2004年 | 361篇 |
2003年 | 256篇 |
2002年 | 195篇 |
2001年 | 143篇 |
2000年 | 142篇 |
1999年 | 107篇 |
1998年 | 88篇 |
1997年 | 81篇 |
1996年 | 81篇 |
1995年 | 68篇 |
1994年 | 70篇 |
1993年 | 52篇 |
1992年 | 43篇 |
1991年 | 30篇 |
1990年 | 36篇 |
1989年 | 40篇 |
1988年 | 29篇 |
1987年 | 30篇 |
1986年 | 18篇 |
1985年 | 24篇 |
1984年 | 16篇 |
1983年 | 17篇 |
1982年 | 19篇 |
1981年 | 16篇 |
1980年 | 10篇 |
1979年 | 13篇 |
1978年 | 12篇 |
1977年 | 4篇 |
1976年 | 9篇 |
1973年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
A. I. Tew 《Medical & biological engineering & computing》1988,26(1):68-74
For some disabled people pointing provides a more convenient means of communication and control than the use of switches.
The quadriplegic who retains good control of head movement can be provided with a number of input alternatives, but no existing
system meets all the requirements of a general-purpose electronic pointing device. Consequently the Oxford Optical Pointer
has been developed. The principle by which it converts relative direction into analogue electrical signals is described and
its application as a head-mounted device for controlling an electric wheelchair is presented. 相似文献
22.
Emad Dean Nukta Bernhard Meier Philip Urban Thierry Muller Pierre A. Dorsaz Josiane Favre 《Catheterization and cardiovascular interventions》1992,25(4):272-277
The Magnum system, initially designed for coronary angioplasty (PTCA) of chronic total occlusion, consists of a balloon catheter and a solid steel 0.021 inch (0.53 mm) steerable and removable wire with a soft and moldable distal portion, tipped with a 1 mm olive. To evaluate its performance in routine PTCA, 200 unselected consecutive patients were randomized to two equal groups, i.e., group Magnum (100 patients, 115 vessels) and group Standard (100 patients, 118 vessels) including 18 and 21 patients with chronic total occlusions, respectively. Randomization was performed by the sealed envelope system in the catheterization laboratory and crossover of system was imposed if it was not possible to place a balloon correctly within 20 min of fluoroscopy time. There were no significant differences between groups concerning clinical and angiographic baseline characteristics, size of initial balloons (3.0±0.3 mm in both groups), fluoroscopy time to cross the lesion with the wire (Magnum: 4±5, Standard: 5±6 min), total fluoroscopy time (Magnum: 11 ± 9, Standard: 12±12 min), and need for crossover (Magnum: 10%, Standard: 16%). Success rates per lesion were comparable with 90% in group Magnum and 84% in group Standard, as were the complications with one inhospital death in group Standard, occurring three weeks after PTCA and stent implantation. There was no emergency operation. Six patients per group had myocardial infarction of whom two in group Magnum and one in group Standard developed a Q-wave. The following variables were significantly in favor of the Magnum system compared with the Standard system: success rate in nontotal lesions (97% versus 90%) crossover success in total occlusions (0 vs. 33%), fluoroscopy time to cross the lesion with the balloon once the wire was in place (1 ± 2 vs. 2 ± 4 min), and use of a single versus 1.2±0.5 wires per lesion. The only advantage of the Standard systems was the more common use of 7 French guiding catheters (Magnum: 40%, Standard: 53%, p = 0.09). The Magnum system compares favorably with standard systems for routine PTCA. The robust design of the Magnum wire does not impair ease of placement and safety but saves material and facilitates balloon advancement across the lesion. 相似文献
23.
24.
Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices
Gopi Dandamudi MD Waqas S. Ghumman MD Mithilesh K. Das MD John M. Miller MD 《Heart rhythm》2007,4(9):1165-1169
BACKGROUND: The outcomes of patients with ventricular assist devices (VADs) who undergo catheter ablation for ventricular tachycardia (VT) have not been reported. OBJECTIVE: The purpose of this study was to assess the feasibility, safety, and efficacy of endocardial VT ablation in patients with VADs. METHODS: We retrospectively reviewed three cases at our institution where endocardial catheter ablation was performed in patients with VADs and incessant VT. RESULTS: Three patients with underlying cardiomyopathies and VADs underwent VT ablation for incessant VT refractory to multiple antiarrhythmic medications. In each case, VT was either eliminated or significantly ameliorated by catheter ablation. No procedure-related complications occurred. The hemodynamic stability afforded by the VAD played an important role in facilitating ablation in two of the cases. CONCLUSION: Catheter ablation for VT in VAD patients appears to be feasible, safe, and effective based on our initial experience. Several technical issues, such as decreases in ventricular volumes that can limit maneuverability of the ablation catheter and potential entrapment of the mapping catheter in the inflow cannula, need to be considered at the time of ablation. 相似文献
25.
Nicholas N Nissen Jeremy Korman Thomas Kleisli Kathy E Magliato 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2005,9(4):481-484
Evaluation and management of abdominal pathology in patients with ventricular assist devices is likely to become increasingly important as the utilization of these devices expands. Ventricular assist devices represent a class of intracorporeal or paracorporeal mechanical devices that augment cardiac output in patients with congestive heart failure. Patients with ventricular assist devices supporting both right and left ventricles (biventricular assist devices) are uniquely challenging to the general surgeon because these devices restrict direct access to the abdominal cavity and because of the perioperative implications of biventricular heart failure. We describe herein the first reported successful laparoscopic cholecystectomy in a patient with a paracorporeal biventricular assist device. Cholecystectomy was performed in this patient for acute cholecystitis that occurred while the patient was awaiting heart transplantation. Our results add weight to the small body of evidence that laparoscopy is well tolerated in ventricular assist devices patients. The unique aspects of the biventricular assist device patient make laparoscopic abdominal intervention particularly suitable in this patient population. 相似文献
26.
27.
Tadashi Nakazawa Yoshiyuki Takami Robert Benkowski Satoshi Ohtsubo Ohashi Yukio Eiki Tayama Goro Ohtsuka Yoshinari Niimi Julie Glueck Akinori Sueoka Helmut Schmallegger Heinrich Schima Ernst Wolner Yukihiko Nosé 《Artificial organs》1997,21(7):597-601
Abstract: To be able to salvage heart failure patients, the need for an economical permanent ventricular assist device is increasing. To meet this increasing demand, a miniaturized centrifugal blood pump has been developed as a permanently implantable device. The Gyro permanently implantable model (PI-601) incorporates a sealless design with a blood stagnation free structure. The pump impeller is magnetically coupled to the driver magnet in a sealless manner. This pump is atraumatic and antithrombogenic and incorporates a double pivot bearing system. A miniaturized actuator was utilized in this system in collaboration with the University of Vienna. The priming volume of this pump is 20 ml. The overall size of the pump actuator package is 53 mm in height and 65 mm in diameter, 145 ml of displacement volume, and 305 g in weight. Testing to date has included in vitro hydraulic performance and hemolysis. This pump can provide 5 L/min against a 110 mm Hg total pressure head at 2,000 rpm and 8 Limin against 150 mm Hg at 2,500 rpm. The normalized index of hemo-lysis (NIH) value of this pump was 0.0028 g/100 L at 5 Limin against 100 mm Hg. A preliminary anatomical study revealed the possibility of the implantability of 2 such systems in biventricular bypass at a preperitoneal location. This system is feasible for use as a permanently implantable biventricular assist device. 相似文献
28.
KEIJU KOTOH KOJI ISHII YOSHINOBU ABE PHILLIP DELEUZE DANIEL LOISANCE 《Artificial organs》1994,18(12):918-922
Abstract: Right ventricular (RV) failure during the use of a left ventricular assist device (LVAD) is the leading cause of death in circulatory support patients. Previous work, both experimentally and clinically, has shown the difficulties in predicting the behavior of the right ventricle at the start of LVAD. An experimental study has been designed to evaluate RV functional changes during LVAD and its relation to preload changes. The model used adult mongrel pigs (n = 10). Right ventricular functional parameters were measured with a thermodilution RV ejection fraction catheter. The left ventricle was supported by a Nippon Zeon blood pump. Two groups were studied, the first one was the LVAD–off group (n = 5) and the other was the LVAD–on group (n = 5) which was supported by LVAD at maximum flow. Change of cardiac output, mean pulmonary artery pressure (PAP), RV stroke work, and RV ejection fraction in both groups were not significantly different. However, the relationship between right ventricular end–diastolic pressure (RV–EDP) and right ventricular stroke volume (RVSV) was significantly changed at a high level of RV–EDP. When RV–EDP was over 6. 5 mm Hg in the LVAD–off group, RVSV decreased to 52. 3 ± 11. 5 ml while in the LVAD–on group, RVSV increased to 97. 2 ± 22. 0 ml. The change in PAP in the LVAD–on group was lower than in the LVAD–off group. We conclude that, at the volume overload state, LVAD can reduce the afterload of the right ventricle and maintain Frank–Starling's effect, thus having a beneficial effect on right ventricular performance. 相似文献
29.
30.
Controlled release of sugar and toxicant from a novel device for controlling pest insects 总被引:1,自引:0,他引:1
Xing Ping Hu Baruch S. Shasha Michael R. McGuire Ronald J. Prokopy 《Journal of controlled release》1998,50(1-3):257-265
A novel biodegradable device, designed for long-lasting residual effectiveness of feeding stimulant (sugar) and insecticide (dimethoate) against apple maggot flies and other insects, was formulated. The device is an 8-cm diameter fruit-mimicking sphere, consisting of 42–50% sugar entrapped in a mixture of gelatinized corn flour and wheat flour in the presence of glycerin, and coated with a layer of latex paint containing dimethoate and sugar. We found that the outer layer of paint prevents cracking of the sphere upon drying and creates a barrier to control the release of both sugar and dimethoate. Releases of each ingredient were screened first by chemical analysis and then by bioassays in the laboratory and in field cages against apple maggot flies. Chemical analysis demonstrated strong potential for controlled release of water-soluble feeding stimulant and water-insoluble insecticide measured as a function of the amount of rainfall and duration of exposure time. Field results showed greater than 70% insecticidal activity after 11 weeks of sphere exposure in an orchard. This device has the potential to be used for a variety of insect-control applications through manipulating its shape, color and texture into forms known to be attractive to target insects, and by employing various toxicants designed to be effective against such insects. 相似文献